Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Medifast, Inc. (MED) Institutional Ownership & Insider Trading

113 institutions reported holding Medifast, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 13 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MEDMedifast, Inc.Follow MED — free
Personal Services · Consumer Cyclical
—
Price chart with a free account
Market cap
132.7M
P/E TTM
—
Dividend yield
0.0%
52-week
—
Next earnings
26 Oct, in 2 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

113 institutions held 73.9% of the shares. Across filers that reported both quarters, shares held changed -3.8%.

Increased+40New+22Decreased-27Closed-20

Largest moves, shares (millions)

Marshall Wace+0.2MTwo Sigma Investments+0.1MCommons Capital+0.1MBlackRock-0.6MMan Group-0.2MCharles Schwab Investment…-0.2M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-1.6Sep 24-0.3Dec 24-0.6Mar 25+0.4Jun 25+0.7Sep 25-1.2Dec 25+0.6Mar 26-0.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 261138-3.8%40222720
Mar 261109+8.3%30192817
Dec 251068-13.4%22114325
Sep 251199+7.6%38172517
Jun 251199+4.7%42193023
Mar 251248-7.1%35184119
Dec 241289-2.8%31134524
Sep 241409-16.5%26175133

Medifast, Inc. — questions

Who owns Medifast, Inc. stock?
113 institutions reported Medifast, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: RENAISSANCE TECHNOLOGIES LLC (7.0%), Steamboat Capital Partners, LLC (6.3%), TWO SIGMA INVESTMENTS, LP (4.3%).
Are Medifast, Inc. insiders buying or selling?
13 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Medifast, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.